Cannabis as a Complementary Treatment in Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CRCHUM, Montreal, Quebec, Canada
Contact: Study coordinator (Amel, Zertal (Project Manager) · amel.zertal.chum@ssss.gouv.qc.ca · 15148908000
Contact: Study coordinator (Dr Pierre, Duquette (PI) · pierre.duquette.med@ssss.gouv.qc.ca · 15148908000

Study leads

Pierre Duquette, MD
Principal Investigator
Centre hospitalier de l'Université de Montréal (CHUM)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)Recruiting

Barcelona, Spain

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

Multiple Sclerosis · Lower Urinary Track Symptoms

Abroad (travel likely)RecruitingPHASE4

Morristown, United States

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Bihać, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Multiple Sclerosis · Sleep · Pain

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States